Eeffect of oral administration of N- acetyl cysteine in Women with Endometriosis

Phase 3

Recruiting

• Conditions: Endometriosis.; Other endometriosis; N80.8

• Registration Number: IRCT20100411003684N9
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Women with endometriosis
?Age 20-35 years old
Laparoscopic diagnosis of endometriosis
Not taking antioxidant supplements
Lack of chronic diseases such as: diabetes- hepatitis- thalassemia anemia-infectious and inflammatory diseases
No clinical or surgical treatment for the past six months
Lack of polycystic ovary

Exclusion Criteria

Non-use of medication
Thalassemia. Diabetes- Hepatitis- Anemia-Infectious and Inflammatory diseases.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Malondialdehyde (MDA). Timepoint: 6 Weeks. Method of measurement: TBARS Method (Spectrophotometry).;Total antioxidant capacity (TAC). Timepoint: 6 Weeks. Method of measurement: FRAP Method.;Blood Iron. Timepoint: 6 Weeks. Method of measurement: Spectrophotometry.;Lactate dehydrogenase (LDH). Timepoint: 6 Weeks. Method of measurement: Spectrophotometry.;8-OH-2-deoxy-Guanosine (8-OHdG). Timepoint: 6 Weeks. Method of measurement: ELISA.;Carbonyl. Timepoint: 6 Weeks. Method of measurement: Levin Method.;DPPH index. Timepoint: 6 Weeks. Method of measurement: Spectrophotometry.